跳至主要内容
临床试验/NCT02306863
NCT02306863Unknown不适用

The Efficacy of Long-term Whole-body Vibration in the Treatment of Parkinson's Disease

Sun Life Financial Movement Disorders Research and Rehabilitation Centre2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2015年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
2
主要终点
Unified Parkinson's Disease Rating Scale (UPDRS) section III

研究概览

简要总结

This study will evaluate whether whole-body vibration applied over a 12-week period is effective in treating motor symptoms of Parkinson's disease.

详细描述

Parkinson's disease (PD) is a progressive neurodegenerative disease resulting in the loss of dopaminergic neurons projecting from the substantia nigra pars compacta to the striatum.

Whole-body vibration (WBV) is potentially beneficial in treating Parkinson's disease because it has been shown to elicit effects specific to both the brain and muscular system. Animal models of PD indicate that whole-body vibration can increase striatal dopamine levels, as well as the number of dopaminergic neurons in the substantia nigra. These findings were correlated with increased levels of brain-derived neurotrophic factor.

In addition to the potentially neuroplastic effects, >20 Hz WBV has been shown to improve muscular performance. Improved muscular performance is believed to be attributed to WBV induced neuromuscular effects rather than muscle hypertrophy, with the specific mechanism defined as the tonic vibration reflex.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with idiopathic Parkinson's Disease by a Neurologist
  • Currently taking anti-Parkinsonian medication
  • Able to stand for 2 minutes without assistance
  • Able to walk 10 meters without assistance
  • Ability to understand English instructions
  • Normal or corrected vision

排除标准

  • A neurological disease other than PD
  • recent stroke
  • cardiovascular disease
  • previous major hemorrhage
  • artificial pacemaker
  • currently pregnant
  • Current participation in any physical therapy or experimental treatments
  • Peripheral neuropathy, severe osteoporosis
  • Visual impairments that cannot be corrected
  • Clinically diagnosed with dementia
  • Greater than mild dementia (screened using Montreal Cognitive Assessment (MOCA) <24 being excluded)

结局指标

主要结局

Unified Parkinson's Disease Rating Scale (UPDRS) section III

时间窗: change from baseline, 12 weeks, and 2 week washout

clinician monitored motor evaluation

次要结局

  • Timed Up & Go (TUG) Test(change from baseline, 12 weeks, and 2 week washout)
  • Gait Assessment(change from baseline, 12 weeks, and 2 week washout)
  • Timed Grooved Pegboard Task(change from baseline, 12 weeks, and 2 week washout)

研究者

发起方
Sun Life Financial Movement Disorders Research and Rehabilitation Centre
申办方类型
Other
责任方
Principal Investigator
主要研究者

Adam Koebel

Undergraduate Thesis Student

Sun Life Financial Movement Disorders Research and Rehabilitation Centre

研究点 (2)

Loading locations...

相似试验